当前位置:首页 - 行情中心 - 贝瑞基因(000710) - 财务分析 - 现金流量表

贝瑞基因

(000710)

  

流通市值:33.94亿  总市值:36.41亿
流通股本:3.30亿   总股本:3.54亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金204,932,500.091,064,649,230.75759,679,533.2485,524,295.91
  收到的税费返还177,278.853,345,900.073,388,626.123,388,626.12
  收到其他与经营活动有关的现金1,612,923.4427,480,795.414,227,870.382,872,499.6
  经营活动现金流入小计206,722,702.381,095,475,926.23767,296,029.7491,785,421.63
  购买商品、接受劳务支付的现金175,435,173.56513,576,328.14421,184,452.67274,648,805.43
  支付给职工以及为职工支付的现金76,841,487.36319,962,324.55240,832,669.78163,134,578.27
  支付的各项税费7,945,156.3149,833,795.3236,091,944.7320,631,683.15
  支付其他与经营活动有关的现金38,133,334.74141,495,745.5393,769,793.4165,272,787.01
  经营活动现金流出小计298,355,151.971,024,868,193.54791,878,860.59523,687,853.86
  经营活动产生的现金流量净额-91,632,449.5970,607,732.69-24,582,830.89-31,902,432.23
二、投资活动产生的现金流量:
  收回投资收到的现金-9,934,868.389,502,364.169,502,364.16
  处置固定资产、无形资产和其他长期资产收回的现金净额6,108,047.8512,066,6806,060,992.232,226,300
  投资活动现金流入小计6,108,047.8522,001,548.3815,563,356.3911,728,664.16
  购建固定资产、无形资产和其他长期资产支付的现金13,395,755.9575,683,852.163,345,002.436,941,835.4
  投资支付的现金6,354,056.2212,062,498.076,476,810.292,222,200
  投资活动现金流出小计19,749,812.1787,746,350.1769,821,812.6939,164,035.4
  投资活动产生的现金流量净额-13,641,764.32-65,744,801.79-54,258,456.3-27,435,371.24
三、筹资活动产生的现金流量:
  吸收投资收到的现金30,000,0001,600,0002,020,000-
  其中:子公司吸收少数股东投资收到的现金-1,600,000--
  取得借款收到的现金106,048,868.9182,848,975.65172,848,975.65149,260,233.43
  收到其他与筹资活动有关的现金9,000,000---
  筹资活动现金流入小计145,048,868.9184,448,975.65174,868,975.65149,260,233.43
  偿还债务支付的现金105,240,917.78141,975,571.33133,696,255.6899,996,255.68
  分配股利、利润或偿付利息支付的现金1,227,568.344,728,898.783,462,275.212,120,005.72
  支付其他与筹资活动有关的现金9,000,00025,688,064.9814,572,959.644,986,669.64
  筹资活动现金流出小计115,468,486.12172,392,535.09151,731,490.53107,102,931.04
  筹资活动产生的现金流量净额29,580,382.7812,056,440.5623,137,485.1242,157,302.39
四、汇率变动对现金及现金等价物的影响-2,225,966.99-3,027,599.87-2,058,048.65-2,104,346.99
五、现金及现金等价物净增加额-77,919,798.1213,891,771.59-57,761,850.72-19,284,848.07
  加:期初现金及现金等价物余额372,204,585.73358,312,814.14358,312,814.14358,312,814.14
  期末现金及现金等价物余额294,284,787.61372,204,585.73300,550,963.42339,027,966.07
补充资料:
  净利润--196,294,138.02--25,410,162.78
  资产减值准备--674,124.35--
  固定资产和投资性房地产折旧-59,359,691.09-31,805,648.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-59,359,691.09-31,805,648.17
  无形资产摊销-4,651,985.12-2,144,195.36
  长期待摊费用摊销-13,596,012.38-5,559,091.7
  处置固定资产、无形资产和其他长期资产的损失--4,998,568.37-11,541.91
  固定资产报废损失-247,351.76-142,109.7
  公允价值变动损失-2,841,154.08--2,203,689.24
  财务费用-9,405,782.45-5,513,610
  投资损失-3,537,842.81--3,257,567.49
  递延所得税--5,320,026.57--645,625.53
  其中:递延所得税资产减少--6,347,290.87--1,596,055.68
    递延所得税负债增加-1,027,264.3-950,430.15
  存货的减少-18,825,960.62-2,078,244.8
  经营性应收项目的减少-63,204,184.84-52,344,486.74
  经营性应付项目的增加--29,678,540.96--125,769,315.32
  其他--2,099,963.83--
  现金的期末余额-372,204,585.73-339,027,966.07
  减:现金的期初余额-358,312,814.14-358,312,814.14
  现金及现金等价物的净增加额-13,891,771.59--19,284,848.07
公告日期2026-04-302026-04-292025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑